🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
30 Servings
Fat/Fatty Acid Product Type
12% Evidence Coverage

Supplement Facts — Evidence Check

Calories
6 {Calories} (2% DV)
Total Fat
0.5 Gram(s) (1% DV)
Superba(TM) Krill
500 mg
100 mg
📊 Market median: 1000.0mg (212 products) 📚 12 studies (Tier A: 0, B: 3)
This product: 100mg
Borage oil
35 mg
Safflower oil
35 mg
Sea Buckthorn oil
35 mg
Sunflower oil
35 mg

Other Ingredients

Gelatin D-Alpha-Tocopheryl Acetate Lemon Oil

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult Female (18 - 50 Years)

Product Information

📋 Directions for Use

DIRECTIONS: Take 1 capsule daily or as recommended by your healthcare professional.

⚠️ Warnings & Precautions

Keep out of reach of children.

Contains Crustacean Shellfish. (Krill)

🧪 Formulation Notes

Dr. Venessa’s Antarctic Krill 369(TM) plus7 is clinically formulated to support overall well-being including heart health, brain health, joint health, healthy inflammation response and women’s health.*

Contains Crustacean Shellfish. (Krill)

Additional Information

Therapeutically formulated to counteract nutrient depletion and minimize prescription interactions.

Store in a cool, dry place.

Specially formulated by Research Scientist Dr. Titus Venessa, Ph.D., Sc.D.

SUPERBA(TM) KRILL

SUPPORTS HEART HEALTH AND OVERALL WELL BEING*

SAFE THERAPEUTIC FORMULAS

Product Details

UPC / SKU 6 06851 60204 4
DSLD Entry Date 2015-05-22
Product Type Fat/Fatty Acid
Form Capsule
DSLD ID 45191
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →